PHAT
Phathom Pharmaceuticals, Inc.
+0.03 (+0.46%)7.73USD369K成交股數625M市值–本益比(近四季)2.6股價營收比+88.0%營收年增(近四季)2026-10-29下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 74.3M+160% | 58.3M+97% | 49.5M+203% | 39.5M+439% | 28.5M+1392% | 29.7M | 16.4M | 7.3M | 1.9M | 0.00 | 0.00 | 0.00 |
| 營業成本 | 15.1M | 12.0M | 6.2M | 5.0M | 3.7M | 3.8M | 2.4M | 1.4M | 426K | 0.00 | 0.00 | 0.00 |
| 毛利 | 59.2M+139% | 46.3M+79% | 43.3M+209% | 34.5M+479% | 24.8M+1569% | 25.8M | 14.0M | 5.9M | 1.5M | 0.00 | 0.00 | 0.00 |
| 毛利率 | 79.7% | 79.4% | 87.5% | 87.2% | 86.9% | 87.1% | 85.6% | 81.2% | 77.7% | – | – | – |
| 研發費用 | 7.8M | 7.8M | 7.0M | 9.1M | 9.2M | 8.6M | 8.7M | 7.4M | 9.4M | 12.3M | 12.8M | 11.5M |
| 銷售管理費用 | 55.3M | 54.0M | 51.6M | 85.3M | 94.5M | 76.7M | 76.1M | 75.9M | 62.0M | 23.4M | 18.9M | 18.6M |
| 營業利益 | −4.0M-95% | −15.5M-74% | −15.3M-78% | −59.9M-22% | −78.9M+13% | −59.4M+67% | −70.8M+123% | −77.3M+157% | −70.0M | −35.7M | −31.7M | −30.1M |
| 營業利益率 | -5.3% | -26.5% | -30.8% | -151.7% | -276.5% | -200.3% | -433.0% | -1,055.4% | -3,658.7% | – | – | – |
| 稅後淨利 | −17.6M-81% | −30.4M-112% | −30.0M-65% | −75.8M-17% | −94.3M+14% | 260M-700% | −85.6M+109% | −91.4M+142% | −82.9M | −43.2M | −41.0M | −37.8M |
| 淨利率 | -23.7% | -52.1% | -60.5% | -191.9% | -330.7% | 874.9% | -523.3% | -1,248.6% | -4,333.3% | – | – | – |
| 稀釋 EPS | -0.21-84% | -0.37-63% | -0.41-69% | -1.05-33% | -1.31-8% | -0.99+30% | -1.32+57% | -1.56+75% | -1.42 | -0.76 | -0.84 | -0.89 |
| 稀釋股數 | 83.7M | 82.1M | 73.4M | 72.5M | 72.0M | 63.2M | 64.6M | 58.6M | 58.4M | 56.8M | 48.5M | 42.4M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 182M | 181M | 135M | 150M | 212M | 297M | 335M | 276M | 322M | 214M | 249M | 130M |
| 應收帳款 | 97.4M | 80.7M | 55.8M | 51.3M | 36.4M | 38.8M | 21.1M | 10.9M | 3.9M | – | – | – |
| 存貨 | 7.7M | 6.5M | 3.6M | 3.4M | 3.2M | 3.2M | 3.1M | 2.2M | 1.5M | 111K | 111K | – |
| 總資產 | 327M | 305M | 240M | 250M | 294M | 378M | 387M | 319M | 356M | 237M | 265M | 144M |
| 有息負債 | 165M | 164M | 207M | 205M | 203M | 201M | 176M | 174M | 149M | 99.3M | 97.8M | 96.6M |
| 總負債 | 671M | 642M | 663M | 656M | 633M | 632M | 574M | 553M | 505M | 255M | 247M | 234M |
| 股東權益 | −344M | −337M | −423M | −406M | −338M | −254M | −187M | −234M | −149M | −17.8M | 17.6M | −90.2M |
| 負債比 | 205.3% | 210.4% | 275.8% | 262.2% | 215.0% | 167.0% | 148.3% | 173.2% | 141.7% | 107.5% | 93.4% | 162.6% |
| 淨現金(現金 − 有息負債) | 17.9M | 17.2M | −71.9M | −55.6M | 9.1M | 95.9M | 159M | 102M | 173M | 114M | 151M | 32.9M |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −15.6M | – | – | −84.9M+23% | – | – | – | −69.0M | – | – | −39.7M |
| 資本支出 | – | 61K | – | – | 18K | – | – | – | 40K | – | – | 214K |
| 自由現金流 | – | −15.7M | – | – | −84.9M+23% | – | – | – | −69.1M | – | – | −39.9M |
| 折舊攤銷 | – | 110K | – | – | 177K | 181K | 200K | 200K | 214K | 100K | 100K | 146K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -26.9% | – | – | -297.9% | – | – | – | -3,611.9% | – | – | – |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 175M
| Reportable Segment Aggregation Before Other Operating | 175M | 100.0% | +216.9% |
|---|
產品／服務2025 年度 · 175M
| Voquezna Product | 175M | 100.0% | +216.6% |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 175M | +216.9% | −221K | -0.1% | -3.03 | −167M |
| FY2024 | 55.3M | +8001.5% | −334K | -0.6% | -5.29 | −267M |
| FY2023 | 682K | – | −202K | -29.6% | -3.93 | −139M |
| FY2022 | 0.00 | – | −198M | –% | -5.05 | −148M |
| FY2021 | – | – | −144M | –% | -3.89 | −149M |
| FY2020 | – | – | −129M | –% | -3.88 | −70.7M |
| FY2019 | – | – | −255M | –% | -22.45 | −36.6M |
| FY2018 | – | – | −1.3M | –% | -0.21 | – |